Form 8-K - Current report:
SEC Accession No. 0001193125-25-043879
Filing Date
2025-03-03
Accepted
2025-03-03 13:55:42
Documents
14
Period of Report
2025-02-28
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d812498d8k.htm   iXBRL 8-K 23966
  Complete submission text file 0001193125-25-043879.txt   185862

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20250228.xsd EX-101.SCH 4469
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20250228_def.xml EX-101.DEF 13887
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20250228_lab.xml EX-101.LAB 23243
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20250228_pre.xml EX-101.PRE 14856
17 EXTRACTED XBRL INSTANCE DOCUMENT d812498d8k_htm.xml XML 6193
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 25696516
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)